Our Products

Our high potent oral solid dosage production facility is focused on two therapeutic areas.

Oncology Therapies

  • Cancer is the second leading cause of morbidity and mortality globally and is estimated to have accounted for 9.6 million deaths in 2018, with 115,950 new cases of cancer and 70,3271 cancer deaths in Nigeria annually.
  • In Nigeria and other parts of Africa, Oncology drugs are scarce and expensive – a significant and unsustainable burden on governments, healthcare systems, insurers and patients – contributing to the high cancer mortality rates in this region and impeding economic development.
  • To this end, Qvex intends to bridge this gap by providing affordable treatments for various types of cancers.

Antiretrovirals

  • NACA estimates that the number of people living with HIV in Nigeria will increase from 1,795,000 in 2020 to 1,898,000 in 2025.
  • The HIV treatment value chain (from education to medication) is organised and centralised in Nigeria, under the oversight of the National Agency for the Control of Aids (NACA) working in close collaboration with international agencies such as U.S. President’s Emergency Plan for AIDS Relief (PEPFAR).
  • Indeed PEPFAR is reported to have invested more than $6 billion in the national HIV/AIDS response in Nigeria, alone since 2003.
  • Qvex is working to ensure there is sufficient affordable antiretrovirals available country wide.

Quality

Our state-of-the-art plant is designed to meet Good Manufacturing Practice (GMP) and WHO pre-qualification standards.

Region Covered

We provide access to affordable medicines in Nigeria and Africa as a whole.

Partnership Opportunity

Entry-level partnership with Qvex to develop the first state-of-the-art fully-integrated pharmaceutical manufacturing plant in West Africa, capable of meeting WHO pre-qualification standards:

  • Serving Nigeria and 14 other African markets.
  • Increasing access to timely treatment by improving quality, availability and affordability, and therefore survival rates.
  • Ensuring a profitable enterprise for the Company and Investors by adhering to international best practices in terms of governance, operations and financial management.
Scroll to Top